| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 26.571 | 44.286 | 63.039 | 59.501 | 74.099 | 97.503 |
| Total Income - EUR | - | - | - | - | 26.571 | 44.286 | 63.039 | 59.501 | 74.100 | 97.503 |
| Total Expenses - EUR | - | - | - | - | 12.592 | 19.983 | 22.544 | 31.214 | 31.422 | 45.520 |
| Gross Profit/Loss - EUR | - | - | - | - | 13.980 | 24.302 | 40.494 | 28.287 | 42.678 | 51.984 |
| Net Profit/Loss - EUR | - | - | - | - | 13.714 | 23.859 | 39.967 | 27.692 | 41.937 | 49.059 |
| Employees | - | - | - | - | 2 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Natival Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 4.820 | 4.469 | 4.237 | 3.979 | 5.453 |
| Current Assets | - | - | - | - | 14.973 | 33.869 | 52.441 | 28.888 | 40.324 | 47.823 |
| Inventories | - | - | - | - | 377 | 248 | 243 | 243 | 291 | 565 |
| Receivables | - | - | - | - | 2.398 | 4.855 | 7.106 | 7.118 | 24.933 | 18.885 |
| Cash | - | - | - | - | 12.198 | 28.766 | 45.092 | 21.527 | 15.100 | 28.373 |
| Shareholders Funds | - | - | - | - | 13.756 | 37.355 | 55.267 | 30.408 | 41.985 | 49.295 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.217 | 1.335 | 1.642 | 2.717 | 2.318 | 3.982 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Natival Med S.r.l.